Clinical Trial Update: First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update covering first-line treatment for metastatic pancreatic adenocarcinoma across Phase 1 and Phase 2, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED